US equities
|
SPCX
$160.75
▲+8.77%
MU
$918.53
▲+2.51%
NVDA
$221.65
▲+2.39%
TSLA
$387.02
▲+3.56%
META
$707.86
▲+1.96%
SNDK
$1,394.24
▲+2.11%
GOOGL
$334.55
▼-1.68%
AAPL
$344.42
▲+1.45%
SPCX
$160.75
▲+8.77%
MU
$918.53
▲+2.51%
NVDA
$221.65
▲+2.39%
TSLA
$387.02
▲+3.56%
META
$707.86
▲+1.96%
SNDK
$1,394.24
▲+2.11%
GOOGL
$334.55
▼-1.68%
AAPL
$344.42
▲+1.45%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by HeartSciences Inc.
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Today 8:30 EDT
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
October 06, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
September 15, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
August 19, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
July 29, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
July 23, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
June 11, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
June 02, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
May 19, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
May 05, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
April 14, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
March 25, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
March 24, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
March 16, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 05, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
January 29, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
December 15, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
September 11, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Announces Conference Participation and Investor Webinar
August 15, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 04, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
June 03, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
